Royal Bank of Canada’s Mural Oncology MURA Stock Holding History

Royal Bank of Canada’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,054	Closed	-$2K	–	7456
2025 Q3	$2K	Buy	1,054 +352	+50%	+$756	﹤0.01%	6889
2025 Q2	$2K	Sell	702 -159,684	-100%	-$376K	﹤0.01%	6807
2025 Q1	$202K	Buy	160,386 +159,978	+39,210%	+$583K	﹤0.01%	4695
2024 Q4	$1K	Buy	408 +250	+158%	+$881	﹤0.01%	6800
2024 Q3	$0	Sell	158 -1,559	-91%	-$5.08K	﹤0.01%	7220
2024 Q2	$6K	Buy	1,717 +656	+62%	+$2.42K	﹤0.01%	6491
2024 Q1	$5K	Sell	1,061 -4,616	-81%	-$22.4K	﹤0.01%	6451
2023 Q4	$34K	Buy	+5,677	New	+$22.8K	﹤0.01%	6141

Royal Bank of Canada's MURA Position: Q4 2025 in Review

Royal Bank of Canada sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1,054 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $202K in Q1 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Royal Bank of Canada reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Royal Bank of Canada sold 1,054 Mural Oncology shares in Q4 2025, an estimated $2K.
Royal Bank of Canada first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Royal Bank of Canada's Mural Oncology position peaked at $202K in Q1 2025.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.